Literature DB >> 2129639

Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs.

T M Shallcross1, B J Rathbone, J I Wyatt, R V Heatley.   

Abstract

Helicobacter pylori is now recognized as a frequent cause of histological chronic gastritis, and this has radically changed our understanding of this common condition. In the light of these developments, the traditional view that non-steroidal anti-inflammatory drugs are one of the common 'environmental' causes of chronic gastritis has been re-examined. Gastric mucosal biopsies have been studied from 430 patients undergoing routine upper gastrointestinal endoscopy, 99 of whom had recently been taking non-steroidal anti-inflammatory drugs. No significant association was found between the use of these drugs and either the presence of chronic gastritis or the frequency of colonization with H. pylori, although there was a strong association (P less than 0.0001) between H. pylori and gastritis. Non-steroidal anti-inflammatory drugs appear, however, to modify the inflammatory process in the gastric body, leading to a lower frequency of atrophic gastritis (P less than 0.05). The majority of peptic ulcers were associated with H. pylori irrespective of non-steroidal anti-inflammatory drug use, but there was a higher frequency of H. pylori negative ulceration in the patients who had used these agents (P less than 0.04). Peptic ulceration was uncommon in the absence of either H. pylori or recent non-steroidal anti-inflammatory drug use.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129639     DOI: 10.1111/j.1365-2036.1990.tb00498.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis.

Authors:  Molly D Magnano; Mark C Genovese
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

2.  Celecoxib inhibits Helicobacter pylori colonization-related factors.

Authors:  Jing Wang; Wei-Hong Wang; Jiang Li; Fang-Xun Liu
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

3.  Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.

Authors:  G Bianchi Porro; F Parente; V Imbesi; F Montrone; I Caruso
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

5.  Helicobacter pylori, gastritis, and peptic ulceration in the elderly.

Authors:  J I Wyatt; T M Shallcross; J E Crabtree; R V Heatley
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

6.  Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold.

Authors:  M Janssen; B A Dijkmans; J P Vandenbroucke; W van Duijn; A S Peña; C B Lamers
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

7.  Does high gastric cancer risk associated with low serum ferritin level reflect achlorhydria? An examination via cross-sectional study.

Authors:  M Kabuto; H Imai; S Tsugane; S Watanabe
Journal:  Jpn J Cancer Res       Date:  1993-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.